REG - Plus500 Ltd - Appointment of Joint Corporate Broker

Plus500Announcement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260505:nRSE9074Ca&default-theme=true

RNS Number : 9074C  Plus500 Limited  05 May 2026

5 May 2026

Plus500 Ltd.

("Plus500", the "Company" or together with its subsidiaries the "Group")

Appointment of Joint Corporate Broker

Plus500, a global multi-asset fintech group operating proprietary
technology-based trading platforms, is pleased to announce the appointment of
Merrill Lynch International ("BofA Securities") as Joint Corporate Broker to
the Company, with immediate effect. BofA Securities will act in such capacity
alongside the Company's existing Corporate Broker, Panmure Liberum Limited.

The Board considers that the appointment further strengthens the Company's
access to global capital markets and supports its continued engagement with a
diverse, high-quality investor base.

For further details:

 Plus500 Ltd.
 Elad Even-Chen, Chief Financial Officer  +972 4 8189503

 Owen Jones, Head of Investor Relations   +44 (0) 7551 654208

                                          ir@Plus500.com (mailto:ir@Plus500.com)

 Panmure Liberum
 Bidhi Bhoma                              +44 20 3100 2000

 Dru Danford

 David Watkins

 Satbir Kler

 BofA Securities
 Yoram Inbar                              +44 20 7628 1000

 Stephen Little

 Fraser Allan

 Joe Weaving

 DGA Group
 James Styles                             +44 (0) 7510 385554

 Corbin Ellington                         Plus500@dgagroup.com (mailto:Plus500@dgagroup.com)

 

 

About Plus500

Plus500 is a global multi-asset fintech group operating proprietary
technology-based trading platforms. Plus500 offers customers a range of
trading products, including OTC ("Over-the-Counter" products, namely Contracts
for Difference (CFDs)), share dealing, as well as futures and options on
futures.

The Group retains operating licences and is regulated in the United Kingdom,
Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the
Seychelles, the United States, Estonia, Japan, the UAE, the Bahamas, Canada,
Colombia and India, and through its OTC product portfolio, offers more than
2,500 different underlying global financial instruments, comprising equities,
indices, commodities, options, ETFs, foreign exchange and cryptocurrencies.
Customers of the Group can trade its OTC products in more than 60 countries
and in 30 languages.

Plus500's trading platforms are accessible from multiple operating systems
(iOS, Android and Windows) and web browsers. Customer care is, and has always
been, integral to Plus500. As such, OTC customers cannot be subject to
negative balances. A free demo account is available on an unlimited basis for
OTC trading platform users and sophisticated risk management tools are
provided free of charge to manage leveraged exposure, and stop losses to help
customers protect profits, while limiting capital losses.

Plus500 was admitted to trading on the London Stock Exchange (LON: PLUS) on 24
July 2013. It was admitted to the Equity Shares in Commercial Companies
("ESCC") Category of the Official List and is a constituent of the FTSE 250
Index and the STOXX Europe 600 Index. Website: www.plus500.com
(http://www.plus500.com/) .

About BofA Securities

BofA Securities, which is authorised by the Prudential Regulation Authority
("PRA") and regulated by the Financial Conduct Authority and the PRA in the
United Kingdom, is acting as joint corporate broker for the Company and for no
one else in connection with such engagement and will not be responsible to
anyone other than the Company for providing the protections afforded to its
clients or for providing advice in relation to the matters referred to in this
announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPUPUMWAUPQGMC



            Copyright 2019 Regulatory News Service, all rights reserved